Ranibizumab

Generic Name : Ranibizumab
Pronunciation : RA-ni-BIZ-oo-mab
TradeName : International- Lucentis.
Why it is prescribed (Indications) :
This medication is a selective vascular endothelial growth factor (VEGF) antagonist, prescribed for neovascular (wet) age-related macular degeneration (AMD- loss of vision) and macular edema following retinal vein occlusion (RVO).
When it is not to be taken (Contraindications) : Contraindicated in patients with eye infections and hypersensitivity.
When it is to be taken :
The recommended dose is 0.5 mg (0.05 mL), to be administered by intravitreal injection once a month.
How it should be taken :
It comes as a solution for injection to be administered by a healthcare provider via an eye.
Special Instruction :
* Caution should be exercised in patients with history of increased eye pressure, undergone for light therapy, any allergy, who are taking other medications, during pregnancy and breastfeeding.
* It may cause vision changes, do not drive a car or operate machinery while taking this medication.
* Perform eye exams regularly while taking this medication.
Side Effects :
Eye - Dry eye, discomfort, foreign body sensation, headache and increased tears.
Miscellaneous - Nausea, nose or throat irritation and seeing floaters or spots.
Other Precautions :
* Avoid excess dosage.
Storage Conditions :
Store it in refrigerator (2°-8°C).